Lapatinib Terminated Phase 2 Trials for Pancreatic Cancer Metastatic Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00447122BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer